The effect of molnupiravir and nirmatrelvir on SARS-CoV-2 genome diversity in severe models of COVID-19.
Saved in:
| Title: | The effect of molnupiravir and nirmatrelvir on SARS-CoV-2 genome diversity in severe models of COVID-19. |
|---|---|
| Authors: | Penrice-Randal R; Department of Infection Biology and Microbiomes, University of Liverpool, Liverpool, England, United Kingdom., Bentley EG; Department of Infection Biology and Microbiomes, University of Liverpool, Liverpool, England, United Kingdom., Sharma P; Department of Infection Biology and Microbiomes, University of Liverpool, Liverpool, England, United Kingdom., Kirby A; Department of Infection Biology and Microbiomes, University of Liverpool, Liverpool, England, United Kingdom., Donovan-Banfield I; Department of Infection Biology and Microbiomes, University of Liverpool, Liverpool, England, United Kingdom.; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, England, United Kingdom., Kipar A; Department of Infection Biology and Microbiomes, University of Liverpool, Liverpool, England, United Kingdom.; Laboratory for Animal Model Pathology, Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zürich, Zürich, Switzerland., Mega DF; Department of Infection Biology and Microbiomes, University of Liverpool, Liverpool, England, United Kingdom., Bramwell C; Department of Infection Biology and Microbiomes, University of Liverpool, Liverpool, England, United Kingdom.; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, England, United Kingdom., Sharp J; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, England, United Kingdom.; Centre of Excellence in Long-acting Therapeutics (CELT), University of Liverpool, Liverpool, England, United Kingdom., Owen A; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, England, United Kingdom.; Centre of Excellence in Long-acting Therapeutics (CELT), University of Liverpool, Liverpool, England, United Kingdom., Hiscox JA; Department of Infection Biology and Microbiomes, University of Liverpool, Liverpool, England, United Kingdom.; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, England, United Kingdom.; A*STAR Infectious Diseases Laboratories (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), , Singapore., Stewart JP; Department of Infection Biology and Microbiomes, University of Liverpool, Liverpool, England, United Kingdom.; Centre of Excellence in Long-acting Therapeutics (CELT), University of Liverpool, Liverpool, England, United Kingdom. |
| Source: | Microbiology spectrum [Microbiol Spectr] 2025 May 06; Vol. 13 (5), pp. e0182924. Date of Electronic Publication: 2025 Mar 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2165-0497 (Electronic) Linking ISSN: 21650497 NLM ISO Abbreviation: Microbiol Spectr Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
